These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17956265)

  • 1. Murine models for chronic lymphocytic leukaemia.
    Michie AM; Nakagawa R; McCaig AM
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1009-12. PubMed ID: 17956265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New directions in the diagnosis and treatment of chronic lymphocytic leukaemia.
    Schriever F; Huhn D
    Drugs; 2003; 63(10):953-69. PubMed ID: 12699399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis.
    Tumilasci VF; Olière S; Nguyên TL; Shamy A; Bell J; Hiscott J
    J Virol; 2008 Sep; 82(17):8487-99. PubMed ID: 18579592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of chronic lymphocytic leukaemia.
    Kalil N; Cheson BD
    Drugs Aging; 2000 Jan; 16(1):9-27. PubMed ID: 10733261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade.
    Herman SE; Wiestner A
    Semin Oncol; 2016 Apr; 43(2):222-32. PubMed ID: 27040700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model.
    Severin F; Urbani A; Varanita T; Bachmann M; Azzolini M; Martini V; Pizzi M; Tos APD; Frezzato F; Mattarei A; Ghia P; Bertilaccio MTS; Gulbins E; Paradisi C; Zoratti M; Semenzato GC; Leanza L; Trentin L; Szabò I
    J Exp Clin Cancer Res; 2022 Feb; 41(1):64. PubMed ID: 35172855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of leukaemia cutis with cladribine in a patient with B-cell chronic lymphocytic leukaemia.
    Robak E; Robak T; Biernat W; Bartkowiak J; Krykowski E
    Br J Dermatol; 2002 Oct; 147(4):775-80. PubMed ID: 12366429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.
    Liu FT; Jia L; Wang P; Wang H; Farren TW; Agrawal SG
    Oncotarget; 2016 May; 7(22):32031-45. PubMed ID: 27074565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors.
    Shcherbina V; Gordiienko I; Shlapatska L; Ivanivska T; Sidorenko S
    Exp Oncol; 2020 Mar; 42(1):16-24. PubMed ID: 32231196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma.
    Kress CL; Konopleva M; Martínez-García V; Krajewska M; Lefebvre S; Hyer ML; McQueen T; Andreeff M; Reed JC; Zapata JM
    PLoS One; 2007 Jun; 2(6):e559. PubMed ID: 17593960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model of chronic lymphocytic leukemia with Ritcher's transformation in severe combined immunodeficiency mice.
    Su YC; Wu WM; Wu MF; Chiang BL
    Exp Hematol; 2001 Oct; 29(10):1218-25. PubMed ID: 11602324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia.
    Maharaj K; Powers JJ; Achille A; Deng S; Fonseca R; Pabon-Saldana M; Quayle SN; Jones SS; Villagra A; Sotomayor EM; Sahakian E; Pinilla-Ibarz J
    Blood Adv; 2018 Nov; 2(21):3012-3024. PubMed ID: 30425065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic alterations in a murine model for chronic lymphocytic leukemia.
    Chen SS; Sherman MH; Hertlein E; Johnson AJ; Teitell MA; Byrd JC; Plass C
    Cell Cycle; 2009 Nov; 8(22):3663-7. PubMed ID: 19901553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect.
    Martinez-Lostao L; Briones J; Martinez-Gallo M; Forné I; Sierra J; Rodriguez-Sanchez JL; Juarez C
    Leuk Lymphoma; 2004 Nov; 45(11):2307-14. PubMed ID: 15512822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.
    Darwiche W; Gubler B; Marolleau JP; Ghamlouch H
    Front Immunol; 2018; 9():683. PubMed ID: 29670635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.
    Pramil E; Herbi Bastian L; Denèfle T; Nemati F; Xiao M; Lardé E; Maloum K; Roos-Weil D; Chapiro E; Le Garff-Tavernier M; Davi F; Decaudin D; Sarfati M; Nguyen-Khac F; Merle-Béral H; Karoyan P; Susin SA
    Blood Adv; 2019 Oct; 3(20):2920-2933. PubMed ID: 31648314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line.
    Agathangelidis A; Scarfò L; Barbaglio F; Apollonio B; Bertilaccio MT; Ranghetti P; Ponzoni M; Leone G; De Pascali V; Pecciarini L; Ghia P; Caligaris-Cappio F; Scielzo C
    PLoS One; 2015; 10(6):e0130195. PubMed ID: 26110819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.